Omega Healthcare Investors (NYSE:OHI) Issues Earnings Results

Omega Healthcare Investors (NYSE:OHI) released its quarterly earnings data on Wednesday. The real estate investment trust reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.33, Zacks reports. Omega Healthcare Investors had a net margin of 34.41% and a return on equity of 8.83%. Omega Healthcare Investors updated its FY 2025 guidance to 2.900-2.980 EPS.

Omega Healthcare Investors Trading Up 1.9 %

Shares of Omega Healthcare Investors stock traded up $0.73 during midday trading on Wednesday, reaching $38.33. 2,807,746 shares of the company’s stock traded hands, compared to its average volume of 1,855,654. Omega Healthcare Investors has a 12 month low of $27.74 and a 12 month high of $44.42. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The stock has a 50 day moving average of $38.16 and a 200-day moving average of $39.08. The company has a market cap of $10.35 billion, a PE ratio of 28.18, a price-to-earnings-growth ratio of 1.08 and a beta of 0.99.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Monday, February 10th will be issued a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, February 10th. This represents a $2.68 dividend on an annualized basis and a yield of 6.99%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Analysts Set New Price Targets

OHI has been the subject of a number of research analyst reports. Royal Bank of Canada boosted their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday, November 11th. BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research note on Thursday, October 31st. Mizuho increased their price objective on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research note on Thursday, December 5th. BMO Capital Markets raised Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective on the stock in a research note on Monday, December 9th. Finally, Berenberg Bank began coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They issued a “buy” rating and a $45.00 price target for the company. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $41.67.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.